Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Computational modeling and multilevel cancer control interventions.

Morrissey JP, Lich KH, Price RA, Mandelblatt J.

J Natl Cancer Inst Monogr. 2012 May;2012(44):56-66. doi: 10.1093/jncimonographs/lgs014.

2.

In search of synergy: strategies for combining interventions at multiple levels.

Weiner BJ, Lewis MA, Clauser SB, Stitzenberg KB.

J Natl Cancer Inst Monogr. 2012 May;2012(44):34-41. doi: 10.1093/jncimonographs/lgs001.

3.

State-of-the-art and future directions in multilevel interventions across the cancer control continuum.

Stange KC, Breslau ES, Dietrich AJ, Glasgow RE.

J Natl Cancer Inst Monogr. 2012 May;2012(44):20-31. doi: 10.1093/jncimonographs/lgs006. Review.

4.

Multilevel factors affecting quality: examples from the cancer care continuum.

Zapka J, Taplin SH, Ganz P, Grunfeld E, Sterba K.

J Natl Cancer Inst Monogr. 2012 May;2012(44):11-9. doi: 10.1093/jncimonographs/lgs005.

5.

Introduction: Understanding and influencing multilevel factors across the cancer care continuum.

Taplin SH, Anhang Price R, Edwards HM, Foster MK, Breslau ES, Chollette V, Prabhu Das I, Clauser SB, Fennell ML, Zapka J.

J Natl Cancer Inst Monogr. 2012 May;2012(44):2-10. doi: 10.1093/jncimonographs/lgs008.

6.

Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.

Bellcross CA, Bedrosian SR, Daniels E, Duquette D, Hampel H, Jasperson K, Joseph DA, Kaye C, Lubin I, Meyer LJ, Reyes M, Scheuner MT, Schully SD, Senter L, Stewart SL, St Pierre J, Westman J, Wise P, Yang VW, Khoury MJ.

Genet Med. 2012 Jan;14(1):152-62. doi: 10.1038/gim.0b013e31823375ea. Epub 2011 Oct 27.

7.

Lynch syndrome screening implementation: business analysis by a healthcare system.

Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS.

Am J Manag Care. 2011 Aug 1;17(8):e288-300.

8.

Who should have genetic testing for the Lynch syndrome?

Burt RW.

Ann Intern Med. 2011 Jul 19;155(2):127-8. doi: 10.7326/0003-4819-155-2-201107190-00009. No abstract available.

PMID:
21768586
9.

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.

10.

Clinically relevant changes in family history of cancer over time.

Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE.

JAMA. 2011 Jul 13;306(2):172-8. doi: 10.1001/jama.2011.955.

11.

Pre- and postassessment of nurse practitioners' knowledge of hereditary colorectal cancer.

Edwards QT, Maradiegue A, Seibert D, Jasperson K.

J Am Acad Nurse Pract. 2011 Jul;23(7):361-9. doi: 10.1111/j.1745-7599.2011.00625.x. Epub 2011 Jun 9.

PMID:
21696485
12.

Factors affecting encouragement of relatives among families with Lynch syndrome to seek medical assessment.

Ishii N, Arai M, Koyama Y, Ueno M, Yamaguchi T, Kazuma K, Muto T.

Fam Cancer. 2011 Dec;10(4):649-54. doi: 10.1007/s10689-011-9462-x.

PMID:
21695501
13.

Limited impact on self-concept in individuals with Lynch syndrome; results from a national cohort study.

Petersen HV, Esplen MJ, Ladelund S, Bernstein I, Sunde L, Carlsson C, Nilbert M.

Fam Cancer. 2011 Dec;10(4):633-9. doi: 10.1007/s10689-011-9459-5.

PMID:
21691837
14.

Management of young onset colorectal cancer: divergent practice in the East of England.

Anning L, Koo N, Neely J, Wells A, Clark SK, Miller R, Will O.

Colorectal Dis. 2011 Sep;13(9):e297-302. doi: 10.1111/j.1463-1318.2011.02685.x.

PMID:
21689352
15.

Genomics and drug response.

Wang L, McLeod HL, Weinshilboum RM.

N Engl J Med. 2011 Mar 24;364(12):1144-53. doi: 10.1056/NEJMra1010600. Review. No abstract available.

16.

Genomics and the continuum of cancer care.

McDermott U, Downing JR, Stratton MR.

N Engl J Med. 2011 Jan 27;364(4):340-50. doi: 10.1056/NEJMra0907178. Review. No abstract available.

17.

Horizon scanning for new genomic tests.

Gwinn M, Grossniklaus DA, Yu W, Melillo S, Wulf A, Flome J, Dotson WD, Khoury MJ.

Genet Med. 2011 Feb;13(2):161-5. doi: 10.1097/GIM.0b013e3182011661.

PMID:
21233720
18.

Risks of presymptomatic direct-to-consumer genetic testing.

Annes JP, Giovanni MA, Murray MF.

N Engl J Med. 2010 Sep 16;363(12):1100-1. doi: 10.1056/NEJMp1006029. Epub 2010 Aug 18. No abstract available.

19.

Preparing for a consumer-driven genomic age.

Evans JP, Dale DC, Fomous C.

N Engl J Med. 2010 Sep 16;363(12):1099-103. doi: 10.1056/NEJMp1006202. Epub 2010 Aug 18. No abstract available.

20.

Ten years on--the human genome and medicine.

Varmus H.

N Engl J Med. 2010 May 27;362(21):2028-9. doi: 10.1056/NEJMe0911933. No abstract available.

Supplemental Content

Support Center